Viewing nowCombinationPimaone S Tablet 60/2.5 mg (Pimasartan, Amlodipine)
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.

MFDS item code 202204664 · Approved 2022.12.27 · Insurance code 657807840
Treatment of essential hypertension not controlled with fimasartan monotherapy
Pimasartan potassium is used primarily in patients with essential hypertension who do not adequately control blood pressure with monotherapy, assisting in blood pressure management. This medication dilates blood vessels and lowers blood pressure, effectively reducing the risk of cardiovascular disease. Therefore, pimasartan potassium contributes to improved hypertension treatment and maintaining health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medication's active ingredients or similar drugs, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, those with moderate to severe liver impairment, those with bile duct obstruction, diabetic patients with certain kidney diseases, and those with specific genetic lactose intolerance should not take this medication. Patients with low blood volume or sodium in their body, those with impaired kidney function, those with renovascular hypertension, patients with heart diseases such as aortic or mitral stenosis, patients with primary aldosteronism, severe hypotension, the elderly, and those who are allergic to certain dyes included in this medication should take this medication cautiously. This medication may cause side effects such as dizziness, headaches, facial swelling, urinary disturbances, insomnia, and flushing, and may rarely cause severe kidney problems or blood pressure drops, so any unusual symptoms should be discussed with medical staff immediately. Patients with hypotension or electrolyte imbalances need to carefully manage their condition before taking this medication and should regularly check blood pressure and potassium levels during treatment. This medication may interact with other antihypertensives, potassium-sparing diuretics, certain antibiotics, pain relievers, etc., so if you are taking any other medications, be sure to inform your healthcare provider and exercise caution. Pregnant or breastfeeding women should avoid taking this medication, especially from the early stages of pregnancy. Children under 18 should avoid taking this medication since its safety and effectiveness have not been established. In the case of overdose, severe hypotension or heart rhythm abnormalities may occur, so it is essential to adhere to the prescribed dosage, and if an overdose occurs, visit a hospital immediately. This medicine should be kept out of reach of children and should not be transferred to another container, as this can lead to deterioration in quality or accidents.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container that blocks light. Additionally, it is advisable to store the medication at room temperature, ideally between 1 to 30 degrees Celsius. This helps maintain the medication's effectiveness and safety.
Yellow, rounded square-shaped film-coated tablet
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Korea Hutech Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.